These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16678363)

  • 21. [Aerogenic immunization against swine erysipelas with Spirovak erysipelas vaccine "Dessau"].
    Urbaneck D; Stöhr P; Michael-Meese M
    Arch Exp Veterinarmed; 1980; 34(1):51-4. PubMed ID: 7416893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of age and maternally-derived antibody status on humoral and cellular immune responses to vaccination of pigs against Erysipelothrix rhusiopathiae.
    Pomorska-Mól M; Markowska-Daniel I; Pejsak Z
    Vet J; 2012 Oct; 194(1):128-30. PubMed ID: 22498786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of antibiotics used as feed additives on the immune effect of erysipelas live vaccine in swine.
    Yamamoto K; Takagi M; Endoh YS; Kijima M; Takahashi T
    J Vet Med B Infect Dis Vet Public Health; 2000 Aug; 47(6):453-60. PubMed ID: 11014067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response of growth agglutinating antibody and protection of pigs inoculated with swine erysipelas live vaccine.
    Sawada T; Muramatsu M; Seto K
    Nihon Juigaku Zasshi; 1979 Dec; 41(6):593-600. PubMed ID: 522336
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of oral vaccination against swine erysipelas in growing-finishing pigs in a clinically infected Slovakian pig herd.
    Friendship CR; Bilkei G
    Vet J; 2007 Jan; 173(1):219-22. PubMed ID: 16249105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and identification of a novel candidate vaccine protein through systematic analysis of extracellular proteins of Erysipelothrix rhusiopathiae.
    Shi F; Ogawa Y; Sano A; Harada T; Hirota J; Eguchi M; Oishi E; Shimoji Y
    Infect Immun; 2013 Dec; 81(12):4333-40. PubMed ID: 24019408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acid-base status and antibody production in pigs immunized with a vaccine against erysipelas].
    Gundasheva D; Andonova M; Ivanov V
    Vet Med Nauki; 1986; 23(4):31-4. PubMed ID: 3488613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of NaOH-extracted Erysipelothrix rhusiopathiae vaccine in pigs.
    Kitajima T; Oishi E; Amimoto K; Ui S; Nakamura H; Okada N; Sasaki O; Yasuhara H
    J Vet Med Sci; 1998 Jan; 60(1):9-14. PubMed ID: 9492354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute nonfatal erysipelas in sows in a commercial farrow-to-finish operation.
    Amass SF; Scholz DA
    J Am Vet Med Assoc; 1998 Mar; 212(5):708-9. PubMed ID: 9524646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of sera from swine immunized with different fractions from broth culture of an attenuated strain of Erysipelothrix rhusiopathiae.
    Sawada T; Takahashi T; Tamura Y
    Nihon Juigaku Zasshi; 1987 Feb; 49(1):37-42. PubMed ID: 3573490
    [No Abstract]   [Full Text] [Related]  

  • 31. Erysipelothrix rhusiopathiae: genetic characterization of midwest US isolates and live commercial vaccines using pulsed-field gel electrophoresis.
    Opriessnig T; Hoffman LJ; Harris DL; Gaul SB; Halbur PG
    J Vet Diagn Invest; 2004 Mar; 16(2):101-7. PubMed ID: 15053359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Protective antigens of the swine erysipelas bacterium (Erysipelothrix rhusiopathiae. 1. Specific demonstration of the protective antigen].
    Rothe F
    Arch Exp Veterinarmed; 1982; 36(2):243-53. PubMed ID: 6808965
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunity of native SpaA and recombinant SpaA-N against Erysipelothrix rhusiopathiae infection in mice].
    Nazierbieke W; Zhang L; He C; Peng Q; Borrathybay E
    Wei Sheng Wu Xue Bao; 2010 Mar; 50(3):367-72. PubMed ID: 20499642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of antibiotics on the immune system of animals. III. Experiments in pgis immunized with live and inactivated swine erysipelas vaccines.
    Tu TD
    Acta Vet Acad Sci Hung; 1981; 28(3):317-31. PubMed ID: 7258020
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
    Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S
    Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of the phenotype and virulence of recent serovar 1a, 1b, and 2a isolates of Erysipelothrix rhusiopathiae in Japan.
    Morimoto M; Kato A; Akaike Y; Nogami K; Ono H; Furusawa T; Kojima H; Sasakawa C
    Vet Microbiol; 2022 Jul; 270():109458. PubMed ID: 35623133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Protective medium for the lyophilization of a live vaccine against swine erysipelas--VR2].
    Khristova Kh; Ninov NV; Dilovska Kh
    Vet Med Nauki; 1984; 21(7-8):57-61. PubMed ID: 6506460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serovar, pathogenicity and antimicrobial susceptibility of erysipelothrix rhusiopathiae isolates from farmed wild boars (Sus scrofa) affected with septicemic erysipelas in Japan.
    Yamamoto K; Kijima M; Takahashi T; Yoshimura H; Tani O; Kojyou T; Yamawaki Y; Tanimoto T
    Res Vet Sci; 1999 Dec; 67(3):301-3. PubMed ID: 10607512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with truncated recombinant protein SpaC of Erysipelothrix rhusiopathiae strain 715 serovar 18 confers protective immunity against challenge with various serovars.
    To H; Someno S; Nagai S; Koyama T; Nagano T
    Clin Vaccine Immunol; 2010 Dec; 17(12):1991-7. PubMed ID: 20926696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.